The North America Sleep Aids Market was worth USD 34.93 billion in 2018 and estimated to be growing at a CAGR of 5.9%, to reach USD 46.52 billion by 2023. The market is showcasing evident potential in the mentioned forecast period. The North America Sleep Aids Market size is increasing, due to the rising geriatric population and increasing sense of awareness among various organizations about sleep disorders. With increasing number of professionals working in night shifts rescheduling their sleeping time, sleeping aids are likely to gain traction in the next few years.
Sleep Aids are basically medical devices or drugs that help a person to fall asleep. Lack of proper sleeps have severe effects on one’s health and work life and it is termed as sleep disorders. Sleep Disorders are generally a result of changes in sleeping patterns caused by medical issues, psychiatric problems, and environmental issues.
The increased usage of alcohol, caffeine, and tobacco has led to increase in cases of sleep disorders in the population. It has been one of the major factors driving the North America Sleep Aids Market. Further, sleep disorder awareness initiative by various organization and Increased demand for sleeping pills as a result of stressful modern lifestyle, have also contribute in the rapid growth of the market. Apart from the drivers, the North America Sleep Aids Market also faces some challenges and restraints which include, patent expiration of treatment pills for sleep disorders and side effects associated with sleeping aids medications.
The North America Sleep Aids Market is segmented on the basis of Sleep disorders, Products and Medication types. Based on sleep disorder the market is segmented under Insomnia, Sleep Apnea, Restless legs syndrome, Narcolepsy and Sleep walking. By product the market is segmented into Mattresses & Pillows, Sleep Laboratories, Medication and Sleep apnea devices. On the basis of Medication types the segmentation is done under Prescription-based Drugs, OTC drugs and Herbal Drugs. Sleep apnea remains to be the fastest growing segment compared to other sleep disorders, whereas Mattresses and pillows are expected to continue leading the North America Sleep Aids Market. On the basis of medication type, prescription medications hold the largest share in the market. On the basis of geographical analysis, the North America Sleep Aids Market is segmented under two countries namely United States and Canada.
The major companies dominating the North America Sleep Aids Market are Sanofi, Pfizer, Koninklijke Philips N.V. (Philips), Merck & Co., Cadwell, Care Fusion Corporation, GlaxoSmithKline Plc, SleepMed, DeVilbiss Healthcare LLC, Natus Medical manufactures.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sleep Disorder
5.1.1 Introduction
5.1.2 Insomnia
5.1.3 Sleep Apnea
5.1.4 Restless legs syndrome
5.1.5 Narcolepsy
5.1.6 Sleep Walking
5.1.6 Y-o-Y Growth Analysis, By Sleep Disorder
5.1.7 Market Attractiveness Analysis, By Sleep Disorder
5.1.8 Market Share Analysis, By Sleep Disorder
5.2 Product
5.2.1 Introduction
5.2.2 Mattresses & Pillows
5.2.3 Sleep Laboratories
5.2.4 Medications
5.2.5 Sleep apnea devices
5.2.6 Y-o-Y Growth Analysis, By Product
5.2.7 Market Attractiveness Analysis, By Product
5.2.8 Market Share Analysis, By Product
5.3 Medication
5.3.1 Introduction
5.3.2 Prescription-based Drugs
5.3.3 OTC Drugs
5.3.4 Herbal Drugs
5.3.5 Y-o-Y Growth Analysis, By Medication
5.3.6 Market Attractiveness Analysis, By Medication
5.3.7 Market Share Analysis, By Medication
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Sleep Disorder
6.1.3.3 By Product
6.1.3.4 By Medication
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Sleep Disorder
6.1.4.3 By Product
6.1.4.4 By Medication
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Sleep Disorder
6.1.5.3 By Product
6.1.5.4 By Medication
6.1.5.5 By Indication
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Sanofi
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck & Co
8.3 Pfizer
8.4 Koninklijke Philips N.V.
8.5 GlaxoSmithKline Plc
8.6 Care Fusion Corporation
8.7 Cadwell
8.8 Sleepmed
8.9 Natus Medical Manufacturers
8.10 DeVilbiss Healthcare LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
